Serous borderline ovarian tumors (clinical features, morphology, treatment)
https://doi.org/10.17650/1994-4098-2012-0-3-4-165-168
Abstract
This article considers the clinical features, morphology and general conteporary principles of treatment of ovarian serous borderline tumors. Despite to presence of several malignant signs in borderline ovarian tumors, disease rather has favorable outcome. It allows to perform the conservative surgery for patient in reproductive age, preserve ovarian tissue and save fertility.
About the Authors
I. Yu. Davydova
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
V. V. Kuznetsov
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
A. I. Karseladze
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
References
1. Longacre T.A., Kempson R.L., Hendrickson M.R. Well differentiated serous neoplasms of the ovary. In: Hendrickson M.R. (ed.) Surface Epithelial Neoplasms of the Ovary. Philadelphia: Hanley and Belfus, 1993:255−306.
2. Seidman J.D., Kurman R.J. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000;31:539−57.
3. McKenney J.K., Balzer B.L., Longacre T.A. Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification. Am J Surg Pathol 2006; 30:614−24.
4. Slomovitz B.M., Caputo T.A., Gretz H.F. 3rd et al. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. Am J Surg Pathol 2002;26:592−600.
5. Bell D.A., Longacre T.A., Prat J. et al. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors workshop perspectives. Hum Pathol 2004;35:934−48.
6. Bell D.A., Scully R.E. Ovarian serous border- line tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990;21:397−403.
7. Burks R.T., Sherman M.E., Kurman R.J. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996;20:1319−30.
8. Eichhorn J.H., Bell D.A., Young R.H. et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999;23:397−409.
9. Prat J., De Nictolis M. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micro- papillary pattern and 20 with microinvasion. Am J Surg Pathol 2002;26:1111−28.
10. Singer G., Oldt R. 3rd, Cohen Y. et al. Mutations in BRAF and KRAS characterize
11. the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 2003;95:484−6.
12. Gilks C.B., Alkushi A., Yue J.J. et al. Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases. Int J Gynecol Pathol 2003;22:29−36.
13. Rollins S.E., Young R.H., Bell D.A. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma. Am J Surg Pathol 2006;30:457−62.
14. Staging Classifications and Clinical Practice Guidelines for Gynaecologic Cancers FIGO Committee on Gynaecologic Oncology, 2006. http://www.rho.org/files/FIGO_ Clinical_practice_guidelines_2000.pdf
15. Longacre T.A., McKenney J.K, Tazelaar H.D. et al. Ovarian serous tumors of low malignant potential (borderline tumors). Outcome-based study of 276 patients with long-term ( 5-year) follow-up. Am J Surg Pathol 2005;29:707−23.
Review
For citations:
Davydova I.Yu., Kuznetsov V.V., Karseladze A.I. Serous borderline ovarian tumors (clinical features, morphology, treatment). Tumors of female reproductive system. 2012;(3-4):165-168. (In Russ.) https://doi.org/10.17650/1994-4098-2012-0-3-4-165-168
Views:
1493
Email this article 